Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalMarket Capitalization

Syndax Pharmaceuticals (SNDX) EBT Margin: 2015-2020

Historic EBT Margin for Syndax Pharmaceuticals (SNDX) over the last 5 years, with Dec 2020 value amounting to -5,226.32%.

  • Syndax Pharmaceuticals' EBT Margin fell 148816.00% to -5,226.32% in Q4 2020 from the same period last year, while for Dec 2020 it was -4,708.17%, marking a year-over-year decrease of 91523.00%. This contributed to the annual value of -1,345.06% for FY2024, which is 10182535.00% down from last year.
  • Syndax Pharmaceuticals' EBT Margin amounted to -5,226.32% in Q4 2020, which was up 0.23% from -5,238.26% recorded in Q3 2020.
  • In the past 5 years, Syndax Pharmaceuticals' EBT Margin registered a high of -1,594.89% during Q4 2017, and its lowest value of -5,238.26% during Q3 2020.
  • Its 3-year average for EBT Margin is -4,500.82%, with a median of -4,544.99% in 2018.
  • Per our database at Business Quant, Syndax Pharmaceuticals' EBT Margin soared by 197,003bps in 2017 and then slumped by 349,274bps in 2018.
  • Over the past 5 years, Syndax Pharmaceuticals' EBT Margin (Quarterly) stood at -3,564.92% in 2016, then soared by 197,003bps to -1,594.89% in 2017, then tumbled by 349,274bps to -5,087.63% in 2018, then spiked by 134,947bps to -3,738.16% in 2019, then tumbled by 148,816bps to -5,226.32% in 2020.
  • Its last three reported values are -5,226.32% in Q4 2020, -5,238.26% for Q3 2020, and -4,382.59% during Q2 2020.